FierceBiotech

Sanofi returns to T-cell engager territory with $1.2B pact for phase 1-stage trispecific

Sanofi has returned to T-cell engager (TCE) territory via an agreement to pay $180 million in the near term for a phase 1-stage trispecific antibody from Kali Therapeutics. The California biotech took ...
BioSpace

Sana’s Cell Therapy Sustains Insulin Production Through 14 Months in a T1D Patient

Sana Biotechnology’s investigational allogeneic islet cell therapy has survived and secreted insulin for more than one year after transplantation in a patient. Sana closed Friday’s trading session at ...
pv magazine International

SERIS builds 22.1%-efficient perovskite-silicon tandem solar cell based on double-sided polysilicon layers

Researchers from the Solar Energy Research Institute of Singapore (SERIS) in Singapore have fabricated a perovskite-silicon tandem solar cell based on a bottom TOPCon device relying on double-sided ...
Seeking Alpha

Array Technologies targets $1.4B–$1.5B in 2026 revenue with record $2.2B order book as international expansion and innovation accelerate

Jennings provided 2026 guidance: "We expect revenue within the range of $1.4 billion to $1.5 billion with adjusted gross margin between 26% and 27%." Adjusted EBITDA for 2026 is projected at $200 ...
The University of Chicago Chronicle

New tech shows promise for ‘engineering’ cells to prevent type 1 diabetes

Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the ...
Wall Street Journal

Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory

Johnson & Johnson JNJ0.33%increase; green up pointing triangle will invest more than $1 billion in a next generation cell therapy manufacturing facility in Montgomery County, Pa. The company said the ...
Penn Live

Big Pharma firm announces plans for $1 billion plant in Pa.

UPDATE: This post was updated at 11:49 a.m. with some remarks from Wednesday’s plant announcement. Another of the world’s top pharmaceutical companies is making Pennsylvania a part of major North ...
IEEE

COMET: Co-Optimization of Memory with Exploratory Technologies for Hybrid and Back-End Gain Cell Arrays

Abstract: Artificial intelligence (AI) accelerators require high-density, high-performance on-chip memory. In this context, refresh-free Gain Cell (GC) memory has been proposed as an addition or ...
siliconera

1.4.5 Terraria Patch Adds Dead Cells and Palworld Crossovers

Things pass by incredibly swiftly in the Bigger and Boulder trailer. So it can be difficult to catch some of the new features. The Dead Cells and Palworld first Terraria crossover references come up ...
MarketWatch

Array completes sale of select spectrum assets to AT&T for $1.018 billion

CHICAGO, Jan. 13, 2026 /PRNewswire/ -- Array Digital Infrastructure, Inc.(SM) (NYSE: AD) (Array(SM) ) today announced the successful closing of the previously announced agreement with AT&T (NYSE: T) ...
Scientific American

Cell Transplant Therapy Offers New Hope for Type 1 Diabetes

Carin Leong: What if people with type 1 diabetes could start making their own insulin? Scientists have just taken a big step in that direction. They treated a patient with 80 million lab-made ...
GEN

Immune Cell Profiling in Type 1 Diabetes Identifies Changes in Memory T Cells and B Cells

Scientists analyzing human and mouse pancreatic lymph nodes (PLNs) and spleens have identified a distinct subset of CD4 memory helper T cells associated with type 1 diabetes (T1D). Reported by ...